Drug Recalls

Fresenius Kabi

Posted on by Editor

Date: 01/08/2021

Product Description

Ketorolac Tromethamine Injection, USP, 30 mg/mL

Recall Reason Description

Presence of particulate matter

Company Name

Fresenius Kabi USA

US FDA Link:https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/fresenius-kabi-issues-voluntary-nationwide-recall-ketorolac-tromethamine-injection-usp-due-presence